Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

I5k initiative

ABSTRACT: i5k initiative

PROVIDER: PRJNA163993 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR121854_1.fastq.gz	Fastqsanger.gz
	DRR121854_2.fastq.gz	Fastqsanger.gz
	DRR124348_subreads.fastq.gz	Fastqsanger.gz
	DRR124349_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1948

Similar Datasets

Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative

Project description:Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative

| PRJNA801718 | ENA

Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative

Project description:Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative

| PRJNA801748 | ENA

The Brazilian Initiative on Precision Medicine (BIPMed)

Project description:The development of precision medicine strategies requires prior knowledge of the genetic background of the target population. However, despite the availability of data from admixed Americans within large reference population databases, we cannot use these data as a surrogate for that of the Brazilian population. This lack of transferability is mainly due to differences between ancestry proportions of Brazilian and other admixed American populations. To address the issue, a coalition of research centres created the Brazilian Initiative on Precision Medicine (BIPMed), an initiative of five Research Innovation and Dissemination Centers (RIDCs) supported by FAPESP.

2020-08-22 | GSE156652 | GEO

Epilepsy Genetics Initiative

Project description:Epilepsy Genetics Initiative

| PRJNA434483 | ENA

Epilepsy Genetics Initiative

Project description:Epilepsy Genetics Initiative

| PRJNA434482 | ENA

Dystrophia Myotonica Biomarker Discovery Initiative

Project description:As part of the Dystrophia Myotonica Biomarker Discovery Initiative (DMBDI) a dataset was obtained from 35 participants, including 31 Myotonic Dystrophy type 1 (DM1) cases and four unaffected controls. All DM1 cases in this research were heterozygous for the abnormally expanded CTG repeat. The mode of the length of the DM1 CTG expansion (Modal Allele Length, MAL) was determined by small-pool PCR of blood DNA for 35/36 patients. For this work we did not attempt to measure the repeat length from muscle, due to a very high degree of repeat instability in muscle cells, and associated difficulties in its experimental measurement. One patient refused blood donation. For each of the 35 blood-donating patients mRNA expression profiling of blood was performed using Affymetrix GeneChip™ Human Exon 1.0 ST microarray. For 28 of 36 patients a successful quadriceps muscle biopsy was obtained. The muscle tissue was mRNA profiled using the same type of microarray. In total, a complete set of samples (blood and muscle) was obtained for 27 of 36 patients; samples were given a disease staging score based on muscle impairment rating. mRNA profiling was carried out by the GeneLogic service lab (on a fee-for-service basis) using standard Affymetrix hybridisation protocol.

2019-05-31 | E-MTAB-7983 | biostudies-arrayexpress

NCI Exceptional Responders Initiative

Project description:NCI Exceptional Responders Initiative

| PRJNA325186 | ENA

NIAID Centralized Sequencing Initiative

Project description:NIAID Centralized Sequencing Initiative

| PRJNA565811 | ENA

NIAID Centralized Sequencing Initiative

Project description:NIAID Centralized Sequencing Initiative

| PRJNA565812 | ENA

50 Helminth Genomes Initiative

Project description:50 Helminth Genomes Initiative